Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
However, our regression analysis, adjusted for confounding factors, showed no significant association between the Y402H genotypes and response to treatment in nAMD patients under the recessive model (p > 0.05).
|
29579408 |
2018 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
To compare the published results of studies on the genotype association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V in cases diagnosed as retinal angiomatous proliferation (RAP) versus neovascular age-related macular degeneration (AMD) or healthy controls.
|
28005184 |
2017 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
CFH Y402H and VEGF Polymorphisms and Anti-VEGF Treatment Response in Exudative Age-Related Macular Degeneration.
|
27404493 |
2016 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study.
|
26132079 |
2015 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
The purpose of this study is to investigate whether the Y402H polymorphism (rs1061170, a T-to-C transition at amino acid position 402) in the complement factor H (CFH) gene have a pharmacogenetics effect on the anti-vascular endothelial growth factor (VEGF) treatment for neovascular age-related macular degeneration (AMD).
|
26411831 |
2015 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
A69S and R38X ARMS2 and Y402H CFH gene polymorphisms as risk factors for neovascular age-related macular degeneration in Poland - a brief report.
|
22293892 |
2012 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes.
|
22705344 |
2012 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration.
|
21232084 |
2011 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
To determine serum vascular endothelial growth factor 165 (VEGF165) levels and the association of the complement factor H gene (CFH) Y402H polymorphism in patients with exudative age-related macular degeneration (AMD) in comparison to unaffected control subjects.
|
21158586 |
2011 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab.
|
19091853 |
2009 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Correlation between CFH Y402H and HTRA1 rs11200638 genotype to typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population.
|
18939352 |
2008 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
|
18852870 |
2008 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Complement factor H Y402H polymorphism and characteristics of exudative age-related macular degeneration lesions.
|
17995985 |
2008 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration.
|
18704199 |
2008 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Complement factor H variant Y402H and basal laminar deposits in exudative age-related macular degeneration.
|
17704937 |
2007 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration.
|
17398321 |
2007 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Assessment of the contribution of the LOC387715 gene polymorphism in a family with exudative age-related macular degeneration and heterozygous CFH variant (Y402H).
|
17285240 |
2007 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients.
|
16877387 |
2006 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Further support for the common variants in complement factor H (Y402H) and LOC387715 (A69S) genes as major risk factors for the exudative age-related macular degeneration.
|
16954704 |
2006 |
Exudative age-related macular degeneration
|
|
0.800 |
GeneticVariation
|
BEFREE |
Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population.
|
16379025 |
2005 |